Molecular magnetic resonance imaging of brain–immune interactions

Frontiers in Cellular Neuroscience

Volumn 8, Issue NOV, 2014, Pages

  Gauberti, Maxime ^a   Montagne, Axel ^a   Quenault, AurÉlien ^a   Vivien, Denis ^a  

^a UNIVERSITÉ DE CAEN   (France)

Author keywords

Alzheimer; Antibody; Hemorrhage; Inflammation; Lymphocytes; Microparticles; Multiple sclerosis; Stroke

Indexed keywords

FERUCARBOTRAN; GADOLINIUM; INTERCELLULAR ADHESION MOLECULE 1; MYELOPEROXIDASE; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN HEMORRHAGE; CELL TRACKING; CEREBROVASCULAR ACCIDENT; ENDOTHELIAL DYSFUNCTION; HUMAN; IMMUNE SYSTEM; MOLECULAR IMAGING; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING;

EID: 84912528051     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00389     Document Type: Article

References (138)

1. Anderson, S. A., Glod, J., Arbab, A. S., Noel, M., Ashari, P., Fine, H. A., et al. (2005). Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 105, 420–425. doi: 10.1182/blood-2004-06–2222
2. Anderson, S. A., Shukaliak-Quandt, J., Jordan, E. K., Arbab, A. S., Martin, R., Mcfar-land, H., et al. (2004). Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Ann. Neurol. 55, 654–659. doi: 10.1002/ana.20066
3. Arbab, A. S., Yocum, G. T., Kalish, H., Jordan, E. K., Anderson, S. A., Khakoo, A. Y., et al. (2004). Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 104, 1217–1223. doi: 10.1182/blood-2004-02–0655
4. Arima, Y., Harada, M., Kamimura, D., Park, J.-H., Kawano, F., Yull, F. E., et al. (2012). Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier. Cell 148, 447–457. doi: 10.1016/j.cell.2012.01.022
5. Atkinson, W., Forghani, R., Wojtkiewicz, G. R., Pulli, B., Iwamoto, Y., Ueno, T., et al. (2012). Ligation of the jugular veins does not result in brain inflammation or demyelination in mice. PLoS ONE 7:e33671. doi: 10.1371/journal.pone.0033671
6. Baeten, K., Hendriks, J. J., Hellings, N., Theunissen, E., Vanderlocht, J., Ryck, L. D., et al. (2008). Visualisation of the kinetics of macrophage infiltration during experimental autoimmune encephalomyelitis by magnetic resonance imaging. J. Neuroimmunol. 195, 1–6. doi: 10.1016/j.jneuroim.2007.11.008
7. Barber, P. A., Foniok, T., Kirk, D., Buchan, A. M., Laurent, S., Boutry, S., et al. (2004). MR molecular imaging of early endothelial activation in focal ischemia. Ann. Neurol. 56, 116–120. doi: 10.1002/ana.20162
8. Bendszus, M., and Stoll, G. (2003). Caught in the act: in vivo mapping of macrophage infiltration in nerve injury by magnetic resonance imaging. J. Neurosci. 23, 10892–10896.
9. Berger, C., Hiestand, P., Kindler-Baumann, D., Rudin, M., and Rausch, M. (2006). Analysis of lesion development during acute inflammation and remission in a rat model of experimental autoimmune encephalomyelitis by visualization of macrophage infiltration, demyelination and blood-brain barrier damage. NMR Biomed. 19, 101–107. doi: 10.1002/nbm.1007
10. Blezer, E. L. A., Deddens, L. H., Kooij, G., Drexhage, J., Van Der Pol, S. M. A., Rei-jerkerk, A., et al. (2014). In vivo MR imaging of intercellular adhesion molecule-1 expression in an animal model of multiple sclerosis. Contrast Media Mol. Imaging. doi: 10.1002/cmmi.1602 [Epub ahead of print].
11. Bourrinet, P., Bengele, H. H., Bonnemain, B., Dencausse, A., Idee, J.-M., Jacobs, P. M., et al. (2006). Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent. Invest. Radiol. 41, 313–324. doi: 10.1097/01.rli.0000197669.80475.dd
12. Bradley, P. P., Christensen, R. D., and Rothstein, G. (1982). Cellular and extracellular myeloperoxidase in pyogenic inflammation. Blood 60, 618–622.
13. Breckwoldt, M. O., Chen, J. W., Stangenberg, L., Aikawa, E., Rodriguez, E., Qiu, S., et al. (2008). Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase. Proc. Natl. Acad. Sci. U.S.A. 105, 18584–18589. doi: 10.1073/pnas.0803945105
14. Briley-Saebo, K. C., Johansson, L. O., Hustvedt, S. O., Haldorsen, A. G., Bjørnerud, A., Fayad, Z. A., et al. (2006). Clearance of iron oxide particles in rat liver: effect of hydrated particle size and coating material on liver metabolism. Invest. Radiol. 41, 560–571. doi: 10.1097/01.rli.0000221321.90261.09
15. Briley-Saebo, K. C., Mani, V., Hyafil, F., Cornily, J.-C., and Fayad, Z. A. (2008). Fractionated feridex and positive contrast: in vivo MR imaging of atherosclerosis. Magn. Reson. Med. 59, 721–730. doi: 10.1002/mrm.21541
16. Brochet, B., Deloire, M. S., Touil, T., Anne, O., Caille, J. M., Dousset, V., et al. (2006). Early macrophage MRI of inflammatory lesions predicts lesion severity and disease development in relapsing EAE. Neuroimage 32, 266–274. doi: 10.1016/j.neuroimage.2006.03.028
17. Burtea, C., Ballet, S., Laurent, S., Rousseaux, O., Dencausse, A., Gonzalez, W., et al. (2012). Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives. Arterioscler. Thromb. Vasc. Biol. 32, e36–e48. doi: 10.1161/atvbaha.112.245415
18. Chapon, C., Franconi, F., Lacoeuille, F., Hindré, F., Saulnier, P., Benoit, J.-P., et al. (2009). Imaging E-selectin expression following traumatic brain injury in the rat using a targeted USPIO contrast agent. MAGMA 22, 167–174. doi: 10.1007/s10334-008-0161-z
19. Chen, J. W., Breckwoldt, M. O., Aikawa, E., Chiang, G., and Weissleder, R. (2008). Myeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis. Brain 131, 1123–1133. doi: 10.1093/brain/awn004
20. Chen, J. W., Pham, W., Weissleder, R., and Bogdanov, A. (2004). Human myeloper-oxidase: a potential target for molecular MR imaging in atherosclerosis. Magn. Reson. Med. 52, 1021–1028. doi: 10.1002/mrm.20270
21. Chen, J. W., Querol Sans, M., Bogdanov, A., and Weissleder, R. (2006). Imaging of myeloperoxidase in mice by using novel amplifiable paramagnetic substrates. Radiology 240, 473–481. doi: 10.1148/radiol.2402050994
22. Chin, C. L., Pai, M., Bousquet, P. F., Schwartz, A. J., O’connor, E. M., Nelson, C. M., et al. (2009). Distinct spatiotemporal pattern of CNS lesions revealed by USPIO-enhanced MRI in MOG-induced EAE rats implicates the involvement of spino-olivocerebellar pathways. J. Neuroimmunol. 211, 49–55. doi: 10.1016/j.jneuroim.2009.03.012
23. Cho, T.-H., Nighoghossian, N., Wiart, M., Desestret, V., Cakmak, S., Berthezène, Y., et al. (2007). USPIO-enhanced MRI of neuroinflammation at the sub-acute stage of ischemic stroke: preliminary data. Cerebrovasc. Dis. 24, 544–546. doi: 10.1159/000111222
24. Connolly, E. S. Jr., Winfree, C. J., Springer, T. A., Naka, Y., Liao, H., et al. (1996). Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J. Clin. Invest. 97, 209–216. doi: 10.1172/JCI118392
25. Corot, C., Petry, K. G., Trivedi, R., Saleh, A., Jonkmanns, C., Le Bas, J. F., et al. (2004). Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging. Invest. Radiol. 39, 619–625. doi: 10.1097/01.rli.0000135980.08491.33
26. Cybulsky, M. I., Iiyama, K., Li, H., Zhu, S., Chen, M., Iiyama, M., et al. (2001). A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Invest. 107, 1255–1262. doi: 10.1172/jci11871
27. Daldrup-Link, H. E., Rudelius, M., Oostendorp, R. A. J., Settles, M., Piontek, G., Metz, S., et al. (2003). Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology 228, 760–767. doi: 10.1148/radiol.2283020322
28. Davies, M. J., Gordon, J. L., Gearing, A. J., Pigott, R., Woolf, N., Katz, D., et al. (1993). The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J. Pathol. 171, 223–229. doi: 10.1002/path.1711710311
29. Deddens, L. H., Van Tilborg, G. A. F., Van Der Toorn, A., Van Der Marel, K., Paulis, L. E. M., Van Bloois, L., et al. (2013). MRI of ICAM-1 upregulation after stroke: the importance of choosing the appropriate target-specific particulate contrast agent. Mol. Imaging Biol. 15, 411–422. doi: 10.1007/s11307-013-0617-z
30. DeLeo, M.J., Gounis, M.J., Hong, B., Ford, J.C., Wakhloo, A.K., and Bogdanov, A.A. (2009). Carotid artery brain aneurysm model: in vivo molecular enzyme-specific MR imaging of active inflammation in a pilot study. Radiology 252, 696–703. doi: 10.1148/radiol.2523081426
31. Denes, A., Vidyasagar, R., Feng, J., Narvainen, J., Mccoll, B. W., Kauppinen, R. A., et al. (2007). Proliferating resident microglia after focal cerebral ischaemia in mice. J. Cereb. Blood Flow Metab. 27, 1941–1953. doi: 10.1038/sj.jcbfm.9600495
32. Desestret, V., Brisset, J. C., Moucharrafie, S., Devillard, E., Nataf, S., Honnorat, J., et al. (2009). Early-stage investigations of ultrasmall superparamagnetic iron oxide-induced signal change after permanent middle cerebral artery occlusion in mice. Stroke 40, 1834–1841. doi: 10.1161/strokeaha.108.531269
33. Dijkhuizen, R. M., Asahi, M., Wu, O., Rosen, B. R., and Lo, E. H. (2002). Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model. Stroke 33, 2100–2104. doi: 10.1161/01.STR.0000023534.37670.F7
34. Dousset, V., Ballarino, L., Delalande, C., Coussemacq, M., Canioni, P., Petry, K. G., et al. (1999a). Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyeli-tis. AJNR Am. J. Neuroradiol. 20, 223–227.
35. Dousset, V., Delalande, C., Ballarino, L., Quesson, B., Seilhan, D., Coussemacq, M., et al. (1999b). In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance. Magn. Reson. Med. 41, 329–333. doi: 10.1002/(SICI)1522-2594(199902)41:2<329::AID-MRM17>3.0.CO;2-Z
36. Dousset, V., Brochet, B., Deloire, M. S., Lagoarde, L., Barroso, B., Caille, J. M., et al. (2006). MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium. AJNR Am. J. Neuroradiol. 27, 1000–1005.
37. Enlimomab Acute Stroke Trial, I. (2001). Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial. Neurology 57, 1428–1434. doi: 10.1212/WNL.57.8.1428
38. Enzmann, G., Mysiorek, C., Gorina, R., Cheng, Y.-J., Ghavampour, S., Hannocks, M.-J., et al. (2013). The neurovascular unit as a selective barrier to polymor-phonuclear granulocyte (PMN) infiltration into the brain after ischemic injury. Acta Neuropathol. 125, 395–412. doi: 10.1007/s00401-012-1076–1073
39. Farr, T. D., Seehafer, J. U., Nelles, M., and Hoehn, M. (2011). Challenges towards MR imaging of the peripheral inflammatory response in the subacute and chronic stages of transient focal ischemia. NMR Biomed. 24, 35–45. doi: 10.1002/nbm.1553
40. Floris, S., Blezer, E. L., Schreibelt, G., Dopp, E., Van Der Pol, S. M., Schadee-Eestermans, I. L., et al. (2004). Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. Brain 127, 616–627. doi: 10.1093/brain/awh068
41. Foley, L. M., Hitchens, T. K., Ho, C., Janesko-Feldman, K. L., Melick, J. A., Bayir, H., et al. (2009). Magnetic resonance imaging assessment of macrophage accumulation in mouse brain after experimental traumatic brain injury. J. Neurotrauma 26, 1509–1519. doi: 10.1089/neu.2008.0747
42. Forghani, R., Wojtkiewicz, G. R., Zhang, Y., Seeburg, D., Bautz, B. R. M., Pulli, B., et al. (2012). Demyelinating diseases: myeloperoxidase as an imaging biomarker and therapeutic target. Radiology 263, 451–460. doi: 10.1148/radiol.12111593
43. Fréchou, M., Beray-Berthat, V., Raynaud, J.-S., Mériaux, S., Gombert, F., Lancelot, E., et al. (2013). Detection of vascular cell adhesion molecule-1 expression with USPIO-enhanced molecular MRIina mouse model of cerebralischemia. Contrast Media Mol. Imaging 8, 157–164. doi: 10.1002/cmmi.1512
44. Gaberel, T., Gakuba, C., Goulay, R., Martinez De Lizarrondo, S., Hanouz, J. L., Emery, E., et al. (2014). Impaired glymphatic perfusion after strokes revealed by contrast-enhanced MRI: a new target for fibrinolysis? Stroke 45, 3092–3096. doi: 10.1161/STROKEAHA.114.006617
45. Gaberel, T., Gakuba, C., Hebert, M., Montagne, A., Agin, V., Rubio, M., et al. (2013). Intracerebral hematomas disappear on T2*-weighted images during nor-mobaric oxygen therapy. Stroke. 44, 3482–3489. doi: 10.1161/STROKEAHA.113.002045
46. Gauberti, M., Martinez De Lizarrondo, S., Orset, C., and Vivien, D. (2014). Lack of secondary microthrombosis after thrombin-induced stroke in mice and non-human primates. J. Thromb. Haemost. 12, 409–414. doi: 10.1111/jth.12487
47. Gauberti, M., Montagne, A., Marcos-Contreras, O. A., Le Béhot, A., Maubert, E., and Vivien, D. (2013). Ultra-sensitive molecular MRI of vascular cell adhesion molecule-1 reveals a dynamic inflammatory penumbra after strokes. Stroke 44, 1988–1996. doi: 10.1161/strokeaha.111.000544
48. Gorelik, M., Orukari, I., Wang, J., Galpoththawela, S., Kim, H., Levy, M., et al. (2012). Use of MR cell tracking to evaluate targeting of glial precursor cells to inflammatory tissue by exploiting the very late antigen-4 docking receptor. Radiology 265, 175–185. doi: 10.1148/radiol.12112212
49. Grieve, S. M., Lønborg, J., Mazhar, J., Tan, T. C., Ho, E., Liu, C.-C., et al. (2013). Cardiac magnetic resonance imaging of rapid VCAM-1 up-regulation in myocardial ischemia-reperfusion injury. Eur. Biophys. J. 42, 61–70. doi: 10.1007/s00249-012-0857-x
50. Heinecke, J. W. (2002). Tyrosyl radical production by myeloperoxidase: a phagocyte pathway for lipid peroxidation and dityrosine cross-linking of proteins. Toxicology 177, 11–22. doi: 10.1016/S0300-483X(02)00192-0
51. Henning, E. C., Ruetzler, C. A., Gaudinski, M. R., Hu, T. C., Latour, L. L., Hal-lenbeck, J. M., et al. (2009). Feridex preloading permits tracking of CNS-resident macrophages after transient middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 29, 1229–1239. doi: 10.1038/jcbfm.2009.48
52. Heyn, C., Ronald, J. A., Mackenzie, L. T., Macdonald, I. C., Chambers, A. F., Rutt, B. K., et al. (2006). In vivo magnetic resonance imaging of single cells in mouse brain with optical validation. Magn. Reson. Med. 55, 23–29. doi: 10.1002/mrm.20747
53. Hoyte, L. C., Brooks, K. J., Nagel, S., Akhtar, A., Chen, R., Mardiguian, S., et al. (2010). Molecular magnetic resonance imaging of acute vascular cell adhesion molecule-1 expression in a mouse model of cerebral ischemia. J. Cereb. Blood Flow Metab. 30, 1178–1187. doi: 10.1038/jcbfm.2009.287
54. Iadecola, C., and Anrather, J. (2011). The immunology of stroke: from mechanisms to translation. Nat. Med. 17, 796–808. doi: 10.1038/nm.2399
55. Jefferson, A., Ruparelia, N., and Choudhury, R. P. (2013). Exogenous micropar-ticles of iron oxide bind to activated endothelial cells but, unlike monocytes, do not trigger an endothelial response. Theranostics 3, 428–436. doi: 10.7150/thno.5895
56. Jefferson, A., Wijesurendra, R. S., Mcateer, M. A., Digby, J. E., Douglas, G., Bannister, T., et al. (2011). Molecular imaging with optical coherence tomography using ligand-conjugated microparticles that detect activated endothelial cells: rational design through target quantification. Atherosclerosis 219, 579–587. doi: 10.1016/j.atherosclerosis.2011.07.127
57. Jendelová, P., Herynek, V., Urdzíková, L., Glogarová, K., Kroupová, J., Andersson, B., et al. (2004). Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J. Neurosci. Res. 76, 232–243. doi: 10.1002/jnr.20041
58. Jin, A. Y., Tuor, U. I., Rushforth, D., Filfil, R., Kaur, J., Ni, F., et al. (2009). Magnetic resonance molecular imaging of post-stroke neuroinflammationwith aP-selectin targeted iron oxide nanoparticle. Contrast Media Mol. Imaging 4, 305–311. doi: 10.1002/cmmi.292
59. Kelly, K. A., Allport, J. R., Tsourkas, A., Shinde-Patil, V. R., Josephson, L., and Weissleder, R. (2005). Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ. Res. 96, 327–336. doi: 10.1161/01.RES.0000155722.17881.dd
60. Kim, J., Kim, D. I., Lee, S.-K., Kim, D. J., Lee, J. E., and Ahn, S. K. (2008). Imaging of the inflammatory response in reperfusion injury after transient cerebral ischemia in rats: correlation of superparamagnetic iron oxide-enhanced magnetic resonance imaging with histopathology. Acta Radiol. 49, 580–588. doi: 10.1080/02841850802020484
61. Kleinschnitz, C., Bendszus, M., Frank, M., Solymosi, L., Toyka, K. V., and Stoll, G. (2003). In vivo monitoring of macrophage infiltration in experimental ischemic brain lesions by magnetic resonance imaging. J. Cereb. Blood Flow Metab. 23, 1356–1361. doi: 10.1097/01.wcb.0000090505.76664.db
62. Klinke, A., Nussbaum, C., Kubala, L., Friedrichs, K., Rudolph, T. K., Rudolph, V., et al. (2011). Myeloperoxidase attracts neutrophils by physical forces. Blood 117, 1350–1358. doi: 10.1182/blood-2010-05–284513
63. Kooi, M. E., Cappendijk, V. C., Cleutjens, K. B. J. M., Kessels, A. G. H., Kitslaar, P. J. E. H. M., Borgers, M., et al. (2003). Accumulation of ultrasmall super-paramagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 107, 2453–2458. doi: 10.1161/01.cir.0000068315.98705.cc
64. Kyritsis, N., Kizil, C., Zocher, S., Kroehne, V., Kaslin, J., Freudenreich, D., et al. (2012). Acute inflammation initiates the regenerative response in the adult zebrafish brain. Science 338, 1353–1356. doi: 10.1126/science.1228773
65. Ladewig, G., Jestaedt, L., Misselwitz, B., Solymosi, L., Toyka, K., Bendszus, M., et al. (2009). Spatial diversity of blood-brain barrier alteration and macrophage invasion in experimental autoimmune encephalomyelitis: a comparative MRI study. Exp. Neurol. 220, 207–211. doi: 10.1016/j.expneurol.2009.08.027
66. Laurent, S., Forge, D., Port, M., Roch, A., Robic, C., Vander Elst, L., et al. (2008). Magnetic iron oxide nanoparticles: synthesis, stabilization, vectoriza-tion, physicochemical characterizations, and biological applications. Chem. Rev. 108, 2064–2110. doi: 10.1021/cr068445e
67. Le Behot, A., Gauberti, M., Martinez De Lizarrondo, S., Montagne, A., Lemarchand, E., Repesse, Y., et al. (2014). GpIbalpha-VWF blockade restores vessel patency by dissolving platelet aggregates formed under very high shear rate in mice. Blood 123, 3354–3363. doi: 10.1182/blood-2013-12–543074
68. Ley, K., Laudanna, C., Cybulsky, M. I., and Nourshargh, S. (2007). Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7, 678–689. doi: 10.1038/nri2156
69. Liesz, A., Zhou, W., Mracsko, E., Karcher, S., Bauer, H., Schwarting, S., et al. (2011). Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain 134, 704–720. doi: 10.1093/brain/awr008
70. Liu, H. L., Chen, P. Y., Yang, H. W., Wu, J. S., Tseng, I. C., Ma, Y. J., et al. (2011). In vivo MR quantification of superparamagnetic iron oxide nanoparticle leakage during low-frequency-ultrasound-induced blood-brain barrier opening in swine. J. Magn. Reson. Imaging 34, 1313–1324. doi: 10.1002/jmri.22697
71. Machtoub, L., Bataveljic, D., and Andjus, P. R. (2011). Molecular imaging of brain lipid environment of lymphocytes in amyotrophic lateral sclerosis using magnetic resonance imaging and SECARS microscopy. Physiol. Res. 60(Suppl. 1), S121–S127.
72. Manninger, S. P., Muldoon, L. L., Nesbit, G., Murillo, T., Jacobs, P. M., and Neuwelt, E. A. (2005). An exploratory study of ferumoxtran-10 nanoparticles as a blood-brain barrier imaging agent targeting phagocytic cells in CNS inflammatory lesions. AJNR Am. J. Neuroradiol. 26, 2290–2300.
73. Mardiguian, S., Serres, S., Ladds, E., Campbell, S. J., Wilainam, P., Mcfadyen, C., et al. (2013). Anti-IL-17A treatment reduces clinical score and VCAM-1 expression detected by in vivo magnetic resonance imaging in chronic relapsing EAE ABH mice. Am. J. Pathol. 182, 2071–2081. doi: 10.1016/j.ajpath.2013.02.029
74. Matsuo, Y., Onodera, H., Shiga, Y., Shozuhara, H., Ninomiya, M., Kihara, T., et al. (1994). Role of cell adhesion molecules in brain injury after transient middle cerebral artery occlusion in the rat. Brain Res. 656, 344–352. doi: 10.1016/0006-8993(94)91478-8
75. Matuszewski, L., Persigehl, T., Wall, A., Schwindt, W., Tombach, B., Fobker, M., et al. (2005). Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency. Radiology 235, 155–161. doi: 10.1148/radiol.2351040094
76. McAteer, M. A., Mankia, K., Ruparelia, N., Jefferson, A., Nugent, H. B., Stork, L. A., et al. (2012). A leukocyte-mimetic magnetic resonance imaging contrast agent homes rapidly to activated endothelium and tracks with atherosclerotic lesion macrophage content. Arterioscler. Thromb. Vasc. Biol. 32, 1427–1435. doi: 10.1161/ATVBAHA.111.241844
77. McAteer, M. A., Schneider, J. E., Ali, Z. A., Warrick, N., Bursill, C. A., Von Zur Muhlen, C., et al. (2008). Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted micropar-ticles of iron oxide. Arterioscler. Thromb. Vasc. Biol. 28, 77–83. doi: 10.1161/ATVBAHA.107.145466
78. McAteer, M. A., Sibson, N. R., Von Zur Muhlen, C., Schneider, J. E., Lowe, A. S., Warrick, N., et al. (2007). In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide. Nat. Med. 13, 1253–1258. doi: 10.1038/nm1631
79. Metz, S., Bonaterra, G., Rudelius, M., Settles, M., Rummeny, E. J., and Daldrup-Link, H. E. (2004). Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur. Radiol. 14, 1851–1858. doi: 10.1007/s00330-004-2405–2402
80. Michalska, M., Machtoub, L., Manthey, H. D., Bauer, E., Herold, V., Krohne, G., et al. (2012). Visualization of vascular inflammation in the atherosclerotic mouse by ultrasmall superparamagnetic iron oxide vascular cell adhesion molecule-1-specific nanoparticles. Arterioscler. Thromb. Vasc. Biol. 32, 2350–2357. doi: 10.1161/atvbaha.112.255224
81. Miller, D. H., Khan, O. A., Sheremata, W. A., Blumhardt, L. D., Rice, G. P., Libonati, M. A., et al. (2003). A controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 348, 15–23. doi: 10.1056/NEJMoa020696
82. Mills, P. H., Hitchens, T. K., Foley, L. M., Link, T., Ye, Q., Weiss, C. R., et al. (2012). Automated detection and characterization of SPIO-labeled cells and capsules using magnetic field perturbations. Magn. Reson. Med. 67, 278–289. doi: 10.1002/mrm.22998
83. Millward, J. M., Schnorr, J., Taupitz, M., Wagner, S., Wuerfel, J. T., and Infante-Duarte, C. (2013). Iron oxide magnetic nanoparticles highlight early involvement of the choroid plexus in central nervous system inflammation. ASN Neuro 5, e00110. doi: 10.1042/an20120081
84. Montagne, A., Gauberti, M., Macrez, R., Jullienne, A., Briens, A., Raynaud, J.-S., et al. (2012). Ultra-sensitive molecular MRI of cerebrovascular cell activation enables early detection of chronic central nervous system disorders. Neuroimage 63, 760–770. doi: 10.1016/j.neuroimage.2012.07.018
85. Morris, J. B., Olzinski, A. R., Bernard, R. E., Aravindhan, K., Mirabile, R. C., Boyce, R., et al. (2008). p38 MAPK inhibition reduces aortic ultrasmall super-paramagnetic iron oxide uptake in a mouse model of atherosclerosis: MRI assessment. Arterioscler. Thromb. Vasc. Biol. 28, 265–271. doi: 10.1161/atvbaha.107. 151175
86. Nahrendorf, M., Jaffer, F. A., Kelly, K. A., Sosnovik, D. E., Aikawa, E., Libby, P., et al. (2006). Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 114, 1504–1511. doi: 10.1161/circulationaha.106.646380
87. Neuwelt, E. A., Várallyay, C. G., Manninger, S., Solymosi, D., Haluska, M., Hunt, M. A., et al. (2007). The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study. Neurosurgery 60, 601–611; discussion 611-602. doi: 10.1227/01.neu.0000255350.71700.37
88. Nighoghossian, N., Wiart, M., Cakmak, S., Berthezène, Y., Derex, L., Cho, T.-H., et al. (2007). Inflammatory response after ischemic stroke: a USPIO-enhanced MRI study in patients. Stroke 38, 303–307. doi: 10.1161/01.STR.0000254548.30258.f2
89. Nkansah, M. K., Thakral, D., and Shapiro, E. M. (2011). Magnetic poly(lactide-co-glycolide) and cellulose particles for MRI-based cell tracking. Magn. Reson. Med. 65, 1776–1785. doi: 10.1002/mrm.22765
90. Oude Engberink, R. D., Blezer, E. L., Dijkstra, C. D., Van Der Pol, S. M., Van Der Toorn, A., and De Vries, H. E. (2010). Dynamics and fate of USPIO in the central nervous system in experimental autoimmune encephalomyelitis. NMR Biomed. 23, 1087–1096. doi: 10.1002/nbm.1536
91. Oude Engberink, R. D., Blezer, E. L., Hoff, E. I., Van Der Pol, S. M., Van Der Toorn, A., Dijkhuizen, R. M., et al. (2008). MRI of monocyte infiltration in an animal model of neuroinflammation using SPIO-labeled monocytes or free USPIO. J. Cereb. Blood Flow Metab. 28, 841–851. doi: 10.1038/sj.jcbfm.9600580
92. Peruzzotti-Jametti, L., Donega, M., Giusto, E., Mallucci, G., Marchetti, B., and Pluchino, S. (2014). The role of the immune system in central nervous system plasticity after acute injury. Neuroscience doi: 10.1016/j.neuroscience.2014.04.036 [Epub ahead of print].
93. Pulli, B., and Chen, J. (2014). Imaging neuroinflammation–from bench to bedside. J. Clin. Cell. Immunol. 5, 2.
94. Querol, M., Chen, J. W., and Bogdanov, A. A. (2006). A paramagnetic contrast agent with myeloperoxidase-sensing properties. Org. Biomol. Chem. 4, 1887–1895. doi: 10.1039/b601540a
95. Querol, M., Chen, J. W., Weissleder, R., and Bogdanov, A. (2005). DTPA-bisamide-based MR sensor agents for peroxidase imaging. Org. Lett. 7, 1719–1722. doi: 10.1021/ol050208v
96. Radermacher, K. A., Beghein, N., Boutry, S., Laurent, S., Vander Elst, L., Muller, R. N., et al. (2009). In vivo detection of inflammation using pegylated iron oxide particles targeted at E-selectin: a multimodal approach using MR imaging and EPR spectroscopy. Invest. Radiol. 44, 398–404. doi: 10.1097/RLI.0b013e318 1a49639
97. Raschzok, N., Muecke, D. A., Adonopoulou, M. K., Billecke, N., Werner, W., Kammer, N. N., etal. (2011). In vitro evaluation of magnetic resonance imaging contrast agents for labeling human liver cells: implications for clinical translation. Mol. Imaging Biol. 13, 613–622. doi: 10.1007/s11307-010-0405-y
98. Rausch, M., Baumann, D., Neubacher, U., and Rudin, M. (2002). In-vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO. NMR Biomed. 15, 278–283. doi: 10.1002/nbm.770
99. Rausch, M., Hiestand, P., Baumann, D., Cannet, C., and Rudin, M. (2003). MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE. Magn. Reson. Med. 50, 309–314. doi: 10.1002/mrm.10541
100. Rausch, M., Hiestand, P., Foster, C. A., Baumann, D. R., Cannet, C., and Rudin, M. (2004). Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: clinical implications for ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. J. Magn. Reson. Imaging 20, 16–24. doi: 10.1002/jmri.20057
101. Rausch, M., Sauter, A., Fröhlich, J., Neubacher, U., Radü, E. W., and Rudin, M. (2001). Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage. Magn. Reson. Med. 46, 1018–1022. doi: 10.1002/mrm.1290
102. Reynolds, P. R., Larkman, D. J., Haskard, D. O., Hajnal, J. V., Kennea, N. L., George, A. J. T., et al. (2006). Detection of vascular expression of E-selectin in vivo with MR imaging. Radiology 241, 469–476. doi: 10.1148/radiol.2412050490
103. Riou, A., Chauveau, F., Cho, T. H., Marinescu, M., Nataf, S., Nighoghossian, N., et al. (2013). MRI assessment of the intra-carotid route for macrophage delivery after transient cerebral ischemia. NMR Biomed. 26, 115–123. doi: 10.1002/ nbm.2826
104. Ruehm, S. G., Corot, C., Vogt, P., Kolb, S., and Debatin, J. F. (2001). Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 103, 415–422. doi: 10.1161/01.CIR.103.3.415
105. Saleh, A., Schroeter, M., Jonkmanns, C., Hartung, H.-P., Mödder, U., and Jander, S. (2004a). In vivo MRI of brain inflammation in human ischaemic stroke. Brain 127, 1670–1677. doi: 10.1093/brain/awh191
106. Saleh, A., Wiedermann, D., Schroeter, M., Jonkmanns, C., Jander, S., and Hoehn, M. (2004b). Central nervous system inflammatory response after cerebral infarction as detected by magnetic resonance imaging. NMR Biomed. 17, 163–169. doi: 10.1002/nbm.881
107. Saleh, A., Schroeter, M., Ringelstein, A., Hartung, H.-P., Siebler, M., Mödder, U., et al. (2007). Iron oxide particle-enhanced MRI suggests variability of brain inflammation at early stages after ischemic stroke. Stroke 38, 2733–2737. doi: 10.1161/strokeaha.107.481788
108. Schneider, C., Schuetz, G., and Zollner, T. M. (2009). Acute neuroinflammation in Lewis rats - a model for acute multiple sclerosis relapses. J. Neuroimmunol. 213, 84–90. doi: 10.1016/j.jneuroim.2009.05.015
109. Schroeter, M., Saleh, A., Wiedermann, D., Hoehn, M., and Jander, S. (2004). Histo-chemical detection of ultrasmall superparamagnetic iron oxide (USPIO) contrast medium uptake in experimental brain ischemia. Magn. Reson. Med. 52, 403–406. doi: 10.1002/mrm.20142
110. Schwartz, M., Kipnis, J., Rivest, S., and Prat,A. (2013). How do immune cells support and shape the brain in health, disease, and aging? J. Neurosci. 33, 17587–17596. doi: 10.1523/JNEUROSCI.3241-13.2013
111. Sekeljic, V., Bataveljic, D., Stamenkovic, S., Ulamek, M., Jablonski, M., Radenovic, L., et al. (2012). Cellular markers of neuroinflammation and neurogenesis after ischemic brain injury in the long-term survival rat model. Brain Struct. Funct. 217, 411–420. doi: 10.1007/s00429-011-0336–337
112. Serres, S., Mardiguian, S., Campbell, S. J., Mcateer, M. A., Akhtar, A., Krapitchev, A., et al. (2011). VCAM-1-targeted magnetic resonance imaging reveals subclinical disease in a mouse model of multiple sclerosis. FASEB J. 25, 4415–4422. doi: 10.1096/fj.11–183772
113. Shapiro, E. M., Sharer, K., Skrtic, S., and Koretsky, A. P. (2006). In vivo detection of single cells by MRI. Magn. Reson. Med. 55, 242–249. doi: 10.1002/mrm.20718
114. Shapiro, E. M., Skrtic, S., and Koretsky, A. P. (2005). Sizing it up: cellular MRI using micron-sized iron oxide particles. Magn. Reson. Med. 53, 329–338. doi: 10.1002/mrm.20342
115. Sigovan, M., Boussel, L., Sulaiman, A., Sappey-Marinier, D., Alsaid, H., Desbleds-Mansard, C., et al. (2009). Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model. Radiology 252, 401–409. doi: 10.1148/radiol.2522081484
116. Sipkins, D. A., Gijbels, K., Tropper, F. D., Bednarski, M., Li, K. C., and Steinman, L. (2000). ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging. J. Neuroimmunol. 104, 1–9. doi: 10.1016/S0165-5728(99)00248-9
117. Stroh, A., Zimmer, C., Werner, N., Gertz, K., Weir, K., Kronenberg, G., et al. (2006). Tracking of systemically administered mononuclear cells in the ischemic brain by high-field magnetic resonance imaging. Neuroimage 33, 886–897. doi: 10.1016/j.neuroimage.2006.07.009
118. Thorek, D. L. J., Chen, A. K., Czupryna, J., and Tsourkas, A. (2006). Superparamag-netic iron oxide nanoparticle probes for molecular imaging. Ann. Biomed. Eng. 34, 23–38. doi: 10.1007/s10439-005-9002–9007
119. Tobin, M. K., Bonds, J. A., Minshall, R. D., Pelligrino, D. A., Testai, F. D., and Lazarov, O. (2014). Neurogenesis and inflammation after ischemic stroke: what is known and where we go from here. J. Cereb. Blood Flow Metab. 34, 1573–1584. doi: 10.1038/jcbfm.2014.130
120. Trivedi, R. A., Mallawarachi, C., U-King-Im, J.-M., Graves, M. J., Horsley, J., God-dard, M. J., et al. (2006). Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler. Thromb. Vasc. Biol. 26, 1601–1606. doi: 10.1161/01.ATV.0000222920.59760.df
121. Tsourkas, A., Shinde-Patil, V. R., Kelly, K. A., Patel, P., Wolley, A., Allport, J. R., et al. (2005). In vivo imaging of activated endothelium using an anti-VCAM-1 magnetooptical probe. Bioconjug. Chem. 16, 576–581. doi: 10.1021/ bc050002e
122. Vellinga, M. M., Geurts, J. J., Rostrup, E., Uitdehaag, B. M., Polman, C. H., Barkhof, F., et al. (2009). Clinical correlations of brain lesion distribution in multiple sclerosis. J. Magn. Reson. Imaging 29, 768–773. doi: 10.1002/jmri.21679
123. Vellinga, M. M., Oude Engberink, R. D., Seewann, A., Pouwels, P. J. W., Wattjes, M. P., Van Der Pol, S. M. A., et al. (2008). Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. Brain 131, 800–807. doi: 10.1093/brain/awn009
124. Vivien, D., Gauberti, M., Montagne, A., Defer, G., and Touze, E. (2011). Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence. J. Cereb. Blood Flow Metab. 31, 2119–2134. doi: 10.1038/jcbfm.2011.127
125. von Elverfeldt, D., Maier, A., Duerschmied, D., Braig, M., Witsch, T., Wang, X., et al. (2014). Dual contrast molecular imaging allows noninvasive characterization of myocardial ischemia/reperfusion injury after coronary vessel occlusion in mice by MRI. Circulation 130, 676–687. doi: 10.1161/circulationaha.113.008157
126. von Zur Muhlen, C., Von Elverfeldt, D., Choudhury, R. P., Ender, J., Ahrens, I., Schwarz, M., et al. (2008). Functionalized magnetic resonance contrast agent selectively binds to glycoprotein IIb/IIIa on activated human platelets under flow conditions and is detectable at clinically relevant field strengths. Mol. Imaging 7, 59–67.
127. Wang, J., and Dore, S. (2007). Inflammation after intracerebral hemorrhage. J. Cereb. Blood Flow Metab. 27, 894–908. doi: 10.1038/sj.jcbfm.9600403
128. Weissleder, R., Stark, D. D., Engelstad, B. L., Bacon, B. R., Compton, C. C., White, D. L., et al. (1989). Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am. J. Roentgenol. 152, 167–173. doi: 10.2214/ajr.152.1.167
129. Wiart, M., Davoust, N., Pialat, J.-B., Desestret, V., Moucharrafie, S., Moucharaffie, S., et al. (2007). MRI monitoring of neuroinflammation in mouse focal ischemia. Stroke 38, 131–137. doi: 10.1161/01.str.0000252159.05702.00
130. Will, O., Purkayastha, S., Chan, C., Athanasiou, T., Darzi, A. W., Gedroyc, W., et al. (2006). Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. Lancet Oncol. 7, 52–60. doi: 10.1016/s1470-2045(05)70537–70534
131. Woodcock, T., and Morganti-Kossmann, M. C. (2013). The role of markers of inflammation in traumatic brain injury. Front. Neurol. 4:18. doi: 10.3389/fneur.2013.00018
132. Woods, M., Woessner, D. E., and Sherry, A. D. (2006). Paramagnetic lanthanide complexes as PARACEST agents for medical imaging. Chem. Soc. Rev. 35, 500–511. doi: 10.1039/b509907m
133. Wu, Y. J., Muldoon, L. L., Varallyay, C., Markwardt, S., Jones, R. E., and Neuwelt, E. A. (2007). In vivo leukocyte labeling with intravenous ferumox-ides/protamine sulfate complex and in vitro characterization for cellular magnetic resonance imaging. Am. J. Physiol. Cell Physiol. 293, C1698–C1708. doi: 10.1152/ajpcell.00215.2007
134. Yancy, A. D., Olzinski, A. R., Hu, T. C.-C., Lenhard, S. C., Aravindhan, K., Gru-ver, S. M., et al. (2005). Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling. J. Magn. Reson. Imaging 21, 432–442. doi: 10.1002/jmri.20283
135. Yang, Y. M., Feng, X. Y., Yin Le, K., Li, C. C., Li, A. N., Jia, J., etal. (2013). In vivo USPIO-enhanced MR signal characteristics of secondary degeneration in the ipsilateral substantia nigra after middle cerebral artery occlusion at 3T. J. Neuroradiol. 40, 198–203. doi: 10.1016/j.neurad.2012.11.002
136. Yang, Y., Yang, Y., Yanasak, N., Schumacher, A., and Hu, T. C.-C. (2010). Temporal and noninvasive monitoring of inflammatory-cell infiltration to myocardial infarction sites using micrometer-sized iron oxide particles. Magn. Reson. Med. 63, 33–40. doi: 10.1002/mrm.22175
137. Ye, Q., Wu, Y. L., Foley, L. M., Hitchens, T. K., Eytan, D. F., Shirwan, H., et al. (2008). Longitudinal tracking of recipient macrophages in a rat chronic cardiac allograft rejection model with noninvasive magnetic resonance imaging using micrometer-sized paramagnetic iron oxide particles. Circulation 118, 149–156. doi: 10.1161/circulationaha.107.746354
138. Zwanenburg, J. J. M., Versluis, M. J., Luijten, P. R., and Petridou, N. (2011). Fast high resolution whole brain T2* weighted imaging using echo planar imaging at 7T. Neuroimage 56, 1902–1907. doi: 10.1016/j.neuroimage.2011.03.046